Advertisement

Topics

InfoBionic Company Profile

05:37 EDT 21st March 2019 | BioPortfolio

InfoBionic is a digital health company focused on creating next generation patient monitoring solutions for chronic disease management with an initial market focus on cardiac arrhythmias. InfoBionic’s lead product, MoMe® Kardia, is the only remote cardiac arrhythmia detection and monitoring system that replicates in-hospital telemetry data, right in the office, by giving physicians 24/7 on-demand access to full disclosure Holter, Event, and MCT data via a HIPAA-compliant portal app. For more information, visit www.infobionic.com.


News Articles [9 Associated News Articles listed on BioPortfolio]

InfoBionic brings in $50mm

Digital health firm InfoBionic Inc. raised $50mm in what looks to be a Series C round to Eagle Investments, Excel Venture Management, Safeguard Scientifics, Zaffre Investments, and Blue Cross and Blue...

InfoBionic secures $50m to support expansion of MoMe Kardia system

The financing round includes participation by Eagle Investments; Excel Venture Management; Safeguard Scientifics; Zaffre Investments, a subsidiary of Blue Cross Blue Shield of Massachusetts; and Blue ...

InfoBionic Secures $50 Million in Financing to Support Continued Growth of the MoMe® Kardia System for Cardiac Arrhythmia Detection

InfoBionic, a digital health company focused on patient-monitoring solutions for chronic disease management, today announced the completion of a $50 million financing to support c...

InfoBionic nets $50 million to support its arrhythmia detection platform

Earlier this year the company signed an exclusive distribution deal with Biotronik to expand access to the device.

InfoBionic gets $50M boost

A round of financing involving Blue Cross and Blue Shield of Kansas, Blue Cross Blue Shield of Massachusetts subsidiary Zaffr -More- 

InfoBionic: Cardiologists Shouldn’t Settle for Incomplete Heart Monitor Reporting

LOWELL, Mass. (PRWEB) March 04, 2019 On average a patient will have 115,000 heart beats in a day or 1.6M heartbeats in 14 days.[1] R...

Heart Disease Affecting More Young Women; InfoBionic Points to Earlier Diagnosis

Women between the ages of 35 and 55 accounted for a 32 percent greater percentage of all heart attacks among women – even as the incidence of heart attacks among similarly aged men remained nearly c...

InfoBionic: Cardiac Monitor Disrupts Current Remote Monitoring with “Full Disclosure Beat-to-Beat” Technology

Legacy devices could only record segments of data over short periods of time – providing only partial data and having it downloaded and analyzed by a third party. A new generation of remote cardiac ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

InfoBionic

InfoBionic is a digital health company focused on creating next generation patient monitoring solutions for chronic disease management with an initial market focus on cardiac arrh...

More Information about "InfoBionic" on BioPortfolio

We have published hundreds of InfoBionic news stories on BioPortfolio along with dozens of InfoBionic Clinical Trials and PubMed Articles about InfoBionic for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of InfoBionic Companies in our database. You can also find out about relevant InfoBionic Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record